These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6211133)

  • 1. Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid.
    Dickinson GM; Droller DG; Greenman RL; Hoffman TA
    Antimicrob Agents Chemother; 1981 Oct; 20(4):481-6. PubMed ID: 6211133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumonia.
    Pagano JS; Sarubbi FA
    Am Fam Physician; 1972 Dec; 6(6):84-91. PubMed ID: 4642154
    [No Abstract]   [Full Text] [Related]  

  • 3. Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
    Landesman SH; Corrado ML; Cherubin CC; Gombert M; Cleri D
    Am J Med; 1980 Jul; 69(1):92-8. PubMed ID: 6446240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperacillin in early neonatal infection.
    Placzek M; Whitelaw A; Want S; Sahathevan M; Darrell J
    Arch Dis Child; 1983 Dec; 58(12):1006-9. PubMed ID: 6559060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical study of moxalactam in the treatment of infections due to gram-negative bacilli.
    DeMaria A; McCabe WR
    Scand J Infect Dis; 1984; 16(1):83-97. PubMed ID: 6695159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
    Schleupner CJ; Engle JC
    Antimicrob Agents Chemother; 1982 Feb; 21(2):327-33. PubMed ID: 6280600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin therapy for Pseudomonas infections.
    Eron LJ; Goldenberg RI; Poretz DM; Park CH
    South Med J; 1983 Jul; 76(7):859-62. PubMed ID: 6223378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse.
    Simon GL; Snydman DR; Tally FP; Gorbach SL
    Antimicrob Agents Chemother; 1980 Jul; 18(1):167-70. PubMed ID: 6448020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Penetration of piperacillin into the cerebrospinal fluid of patients with purulent meningitis].
    Decazes JM; Meulemans A; Bure A; Laisne MJ; Modai J
    Presse Med; 1984 Feb; 13(5):261-4. PubMed ID: 6229775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and bacteriological evaluation of the efficacy of piperacillin in children with pneumonia.
    Aoki M; Fukao T; Kaneko H; Mizunaga S; Mitsuyama J; Sawamura H; Seishima M; Kondo N
    J Infect Chemother; 2007 Aug; 13(4):224-9. PubMed ID: 17721685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR; Greenman RL; Hoffman TA
    Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bronchial diffusion of piperacillin in 18 intensive care patients].
    Mouton Y; Caillaux M; Deboscker Y; Beuscart C; Beaucaire G; Fourrier A
    Pathol Biol (Paris); 1985 May; 33(5):359-62. PubMed ID: 3897966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of piperacillin into bronchial mucosa and sputum.
    Marlin GE; Burgess KR; Burgoyne J; Funnell GR; Guinness MD
    Thorax; 1981 Oct; 36(10):774-80. PubMed ID: 6460337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary report comparing piperacillin and carbenicillin for complicated urinary tract infections.
    Swarifi R; Lee M; Ojeda L; Tabib M
    J Urol; 1982 Oct; 128(4):755-8. PubMed ID: 6216344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of piperacillin in bronchopulmonary infection.
    Marlin GE; Burgess KR; Thompson PJ
    J Int Med Res; 1981; 9(4):268-73. PubMed ID: 6455317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli.
    Kern W; Kennedy SL; Sachdeva M; Sande ER; Gunderson D; Täuber MG
    Antimicrob Agents Chemother; 1990 May; 34(5):697-701. PubMed ID: 2163241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamase.
    Leleu G; Kitzis MD; Vallois JM; Gutmann L; Decazes JM
    Antimicrob Agents Chemother; 1994 Feb; 38(2):195-9. PubMed ID: 8192442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic and clinical studies with meropenem in the pediatric field. Pediatric Study Group of Meropenem].
    Fujii R; Yoshioka H; Fujita K; Maruyama S; Sakata H; Inyaku F; Chiba S; Tsutsumi H; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1992 Jun; 45(6):697-717. PubMed ID: 1507401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of piperacillin therapy for infection.
    Pancoast S; Prince AS; Francke EL; Neu HC
    Arch Intern Med; 1981 Oct; 141(11):1447-50. PubMed ID: 6456708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbenicillin therapy of gram-negative bacilli infections.
    Bodey GP; Rodriguez V; Luce JK
    Am J Med Sci; 1969 Jun; 257(6):408-14. PubMed ID: 4893148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.